SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J. L. Hou, Z. L. Gao, Q. Xie, J. M. Zhang, J. F. Sheng, J. Cheng, C. W. Chen, Q. Mao, W. Zhao, H. Ren, D. M. Tan, J. Q. Niu, S. J. Chen, C. Pan, H. Tang, H. Wang, Y. M. Mao, J. D. Jia, Q. Ning, M. Xu, S. M. Wu, J. Li, X. X. Zhang, Y. Ji, J. Dong, J. Li, Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial, Journal of Viral Hepatitis, 2015, 22, 2
  2. 2
    Miriam Romero, Antonio Madejón, Javier García-Samaniego, ¿Es útil la cuantificación de los niveles del HBsAg en el control del paciente con infección crónica por el virus de la hepatitisB?, Gastroenterología y Hepatología, 2014, 37, 6, 350

    CrossRef

  3. 3
    Toshihiro Kawaguchi, Ichiro Miyajima, Ryohei Kaji, Sigenari Sakakibara, Atsusi Mori, Tomoyuki Nakane, Kensuke Miyahara, Ryuichiro Maekawa, Yoichi Yano, Takuji Torimura, Michio Sata, A case of HBsAg seroclearance by readministration of lamivudine and adefovir dipivoxil in patient with liver cirrhosis due to hepatitis B virus infection, Kanzo, 2014, 55, 11, 706

    CrossRef

  4. 4
    Sung-Kwan Suh, Seongeun Song, Heung-Bum Oh, Sang-Hyun Hwang, Sang Soo Hah, Aptamer-based competitive binding assay for one-step quantitation of hepatitis B surface antigen, The Analyst, 2014, 139, 17, 4310

    CrossRef

  5. 5
    Zhaoxia Tan, Maoshi Li, Xuemei Kuang, Yu Tang, Yi Fan, Guohong Deng, Yuming Wang, Dengming He, Clinical implications of hepatitis B surface antigen quantitation in the natural history of chronic hepatitis B virus infection, Journal of Clinical Virology, 2014, 59, 4, 228

    CrossRef

  6. 6
    Jong Eun Yeon, Clinical Significance of Hepatitis B Surface Antigen Quantification in Chronic Hepatitis B, The Korean Journal of Gastroenterology, 2014, 63, 6, 335

    CrossRef

  7. 7
    Norio Akuta, Fumitaka Suzuki, Mariko Kobayashi, Tasuku Hara, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Kenji Ikeda, Hiromitsu Kumada, Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis, Journal of Medical Virology, 2014, 86, 1
  8. 8
    Simon B. Larsson, Anders Eilard, Sebastian Malmström, Charles Hannoun, Amar P. Dhillon, Gunnar Norkrans, Magnus Lindh, HBsAg quantification for identification of liver disease in chronic hepatitis B virus carriers, Liver International, 2014, 34, 7
  9. 9
    Won Sohn, Yong-Han Paik, Jong Man Kim, Choon Hyuk Kwon, Jae Won Joh, Ju Yeon Cho, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma, Annals of Surgical Oncology, 2014, 21, 7, 2429

    CrossRef

  10. 10
    Inês Pita, Ana Maria Horta-Vale, Hélder Cardoso, Guilherme Macedo, Hepatitis B inactive carriers: An overlooked population?, GE Portuguese Journal of Gastroenterology, 2014, 21, 6, 241

    CrossRef

  11. You have free access to this content11
    Sadahisa Okuhara, Takeji Umemura, Satoru Joshita, Soichiro Shibata, Takefumi Kimura, Susumu Morita, Michiharu Komatsu, Akihiro Matsumoto, Kaname Yoshizawa, Yoshihiko Katsuyama, Masao Ota, Eiji Tanaka, Serum levels of interleukin-22 and hepatitis B core-related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B, Hepatology Research, 2014, 44, 10
  12. 12
    Timothy M. Block, Robert Gish, Haitao Guo, Anand Mehta, Andrea Cuconati, W. Thomas London, Ju-Tao Guo, Chronic hepatitis B: What should be the goal for new therapies?, Antiviral Research, 2013, 98, 1, 27

    CrossRef

  13. 13
    Kathrine Stene-Johansen, Regine Barlinn, Diagnostikk av kronisk hepatitt B-infeksjon, Tidsskrift for Den norske legeforening, 2013, 133, 16, 1717

    CrossRef

  14. 14
    Chien-Wei Su, Chun-Ying Wu, Hung-Hsu Hung, Chu-Hui Wu, I-Jane Sheen, Jaw-Ching Wu, Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy, Journal of Gastroenterology and Hepatology, 2013, 28, 12
  15. 15
    Daniel Shouval, Focus, Journal of Hepatology, 2013, 59, 6, 1151

    CrossRef

  16. 16
    Michelle Martinot-Peignoux, Roberto Carvalho-Filho, Martine Lapalus, Ana Carolina Ferreira Netto-Cardoso, Olivier Lada, Richard Batrla, Friedemann Krause, Tarik Asselah, Patrick Marcellin, Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients, Journal of Hepatology, 2013, 58, 6, 1089

    CrossRef

  17. 17
    Stéphane Chevaliez, Is HBsAg quantification ready, for prime time?, Clinics and Research in Hepatology and Gastroenterology, 2013, 37, 6, 559

    CrossRef

  18. 18
    Stéphane Chevaliez, Christophe Hézode, Stéphane Bahrami, Marion Grare, Jean-Michel Pawlotsky, Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely, Journal of Hepatology, 2013, 58, 4, 676

    CrossRef

  19. 19
    Wen-Juei Jeng, I-Shyan Sheen, Yi-Cheng Chen, Chao-Wei Hsu, Rong-Nan Chien, Chia-Ming Chu, Yun-Fan Liaw, Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients, Hepatology, 2013, 58, 6
  20. 20
    B. Zhou, M. Liu, G. Lv, H. Zheng, Y. Wang, J. Sun, J. Hou, Quantification of hepatitis B surface antigen and E antigen: correlation between Elecsys and Architect assays, Journal of Viral Hepatitis, 2013, 20, 6
  21. 21
    Xiaoyan Lei, Xia Gao, Julan Yang, Yonghong Sun, Yipa Sai, Wenping You, Hong Yuan, The genotype C could play a key role in hepatitis B virus associated nephritis among the Northwest Chinese children, European Journal of Internal Medicine, 2013, 24, 8, 835

    CrossRef

  22. 22
    Yi-Cheng Chen, Yun-Fan Liaw, The Role of HBsAg Quantification in the Natural Course of HBV Infection in Asia, Current Hepatitis Reports, 2013, 12, 3, 174

    CrossRef

  23. 23
    Tadashi Inuzuka, Yukio Osaki, Fumihiro Matsuda, Azusa Sakamoto, Keiichi Hatamaru, Shinichiro Henmi, Tetsuro Ishikawa, Sumio Saito, Hiroki Nishikawa, Ryuichi Kita, Yoshihiro Okabe, Toru Kimura, Tomoko Wakasa, Satoru Hagiwara, Masatoshi Kudo, A case of chronic hepatitis B which achieved hepatitis B surface antigen seroclearance during combination therapy with peginterferon alfa-2b and entecavir, Kanzo, 2012, 53, 1, 42

    CrossRef

  24. 24
    Kun-Teng Wang, Shu-Ching Weng, Ching-Pang Chou, Daniel Yang-Chih Shih, Chi-Fang Lo, Der-Yuan Wang, Collaborative study to establish a proficiency panel of hepatitis B surface antigens for evaluating in vitro diagnostics, Biologicals, 2012, 40, 6, 445

    CrossRef

  25. 25
    Brian J. McMahon, Brenna C. Simons, Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay?, Clinical Gastroenterology and Hepatology, 2012, 10, 3, 218

    CrossRef

  26. 26
    Shannan R. Tujios, William M. Lee, New advances in chronic hepatitis B, Current Opinion in Gastroenterology, 2012, 28, 3, 193

    CrossRef

  27. 27
    E. Bouthry, A. Pivert, A. Ducancelle, F. Lunel-Fabiani, Quantification de l’antigène HBs : intérêts et limites dans le suivi des patients infectés par le virus de l’hépatite B, Immuno-analyse & Biologie Spécialisée, 2012, 27, 6, 332

    CrossRef